Effects of ezetimibe on glucose metabolism in patients with glucose intolerance
Not Applicable
- Conditions
- Dyslipidemia
- Registration Number
- JPRN-UMIN000003165
- Lead Sponsor
- Yokohama Sakae Kyosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Poorly controlled diabetes mellitus (HbA1c >8%) 2)Established treatment with colestimide, alufa-GI or insulin 3)Hepatic disorder 4)Renal dysfunction 5)Acute myocardial infarction, unstable angina and stroke within 3 months of enrollment 6)Secondary hyperlipidemia or drug-induced hyperlipidemia 7)Familial hyperlipidemia 8)Ineligible in the opinion of the investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)The change in markers of glucose metabolism 2)The change in serum lipids levels 3)The change in serum hs-CRP level 4)The change in serum adiponectin concentration
- Secondary Outcome Measures
Name Time Method